Pharmacologic treatment of tic disorders

Child and Adolescent Psychiatric Clinics of North America

Volumn 9, Issue 1, 2000, Pages 99-117

  Scahill, L ^a   Chappell, P B ^a   King, R A ^a   Leckman, J F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CLONIDINE; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; PERGOLIDE; PIMOZIDE; PLACEBO; RISPERIDONE; TETRABENAZINE; TIAPRIDE; ZIPRASIDONE;

ADULT; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE DURATION; GILLES DE LA TOURETTE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; REVIEW; TIC; TREATMENT PLANNING;

EID: 0034058740     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1056-4993(18)30137-8     Document Type: Review

References (100)